Kane Biotech

Kane Biotech P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Kane Biotech (KNE.V) as of Oct 16, 2026 is -2.23. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -1.77 — a change of 26.29% (lower).

P/CF

-2.23

YoY

26.29%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Kane Biotech is 2025 -2.23 . P/CF (Price-to-Cash-Flow Ratio) of Kane Biotech was 2024 -1.77 . It decreases by 26.29% lower compared to the previous year.

The Kane Biotech P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
-2.55 CAD
Jan 1, 2019
-7.60 CAD
Jan 1, 2020
-1.84 CAD
Jan 1, 2021
-3.17 CAD
Jan 1, 2022
-2.39 CAD
Jan 1, 2023
-3.49 CAD
Jan 1, 2024
-1.77 CAD
Jan 1, 2025
-2.23 CAD
The Kane Biotech P/CF history
YEARP/CFYoY
-2.23+26.29%
-1.77-49.36%
-3.49+46.17%
-2.39-24.78%
-3.17+72.07%
-1.84-75.75%
-7.60+198.73%
-2.55-28.37%
-3.55+15.61%
-3.07-41.25%
-5.23-24.44%
-6.92—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kane Biotech Stock analysis

What does Kane Biotech do? Kane Biotech Inc is a biotechnology company based in Winnipeg, Manitoba, Canada. The company went public on May 7, 2003, with its stock ticker KNE.V and ISIN CA4838092084. Kane Biotech focuses on researching, developing, and commercializing technologies and products designed to prevent and remove microbial biofilms. The company's product portfolio includes StrixNB, DispersinB, Aledex, bluestem (available in water additives, chews, spray, and dental wipes), silkstem, goldstem, coactiv+, and DermaKB Biofilm. Its Wound Care & Surgical division is developing DispersinB for chronic wound care applications. The company also offers products such as Scalp Detoxifier, Shampoo, and Shampoo Bars. Kane Biotech's primary market focus is on animal health, though it also develops products for human wound care and surgical applications. The company's product development includes Coactiv+ as an antimicrobial wound rinse and surgical hydrogel, as well as DispersinB Gel for prosthetic joint infections. Kane Biotech operates within the Health Care sector, specifically in the Biotechnology industry. The company's website is https://kanebiotech.com/ and it is headquartered in Winnipeg, Canada. Kane Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kane Biotech stock

P/CF (Price-to-Cash-Flow Ratio) of Kane Biotech is -2.23 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Kane Biotech changed from -1.77 to -2.23, representing a 26.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Kane Biotech since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Kane Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Kane Biotech

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Kane Biotech